UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: Levaxin-200mg-Tablet-SE-BS-APD - JSON Representation

Raw json | Download


{
  "resourceType" : "AdministrableProductDefinition",
  "id" : "Levaxin-200mg-Tablet-SE-BS-APD",
  "meta" : {
    "profile" : [
      🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition Levaxin-200mg-Tablet-SE-BS-APD</b></p><a name=\"Levaxin-200mg-Tablet-SE-BS-APD\"> </a><a name=\"hcLevaxin-200mg-Tablet-SE-BS-APD\"> </a><a name=\"hcLevaxin-200mg-Tablet-SE-BS-APD-en-US\"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-Levaxin-200mg-Tablet-SE-BS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-XXXXXXXXX-00021055,http://ema.europa.eu/fhir/eurdId#1860; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Hypotyreos av alla former t ex vid autoimmun tyreoidit, efter radiojod- och kirurgisk terapi av hypertyreos och vid progressiv oftalmopati när den är förenad med hypotyreos.  Som tillägg till tyreostatika vid långtidsbehandling av hypertyreos och vid preoperativ kombinationsbehandling av hypertyreos. Tyreoideacancer. Myxödemkoma.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = levothyroxine sodium</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}\">Tablet</span></p><p><b>producedFrom</b>: <a href=\"ManufacturedItemDefinition-Levaxin-200mg-Tablet-SE-BS-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073619}\">Oral use</span></td></tr></table></div>"
  },
  "status" : "active",
  "formOf" : [
    {
      🔗 "reference" : "MedicinalProductDefinition/Levaxin-200mg-Tablet-SE-BS-MPD"
    }
  ],
  "administrableDoseForm" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
        "code" : "100000073664",
        "display" : "Tablet"
      }
    ]
  },
  "producedFrom" : [
    {
      🔗 "reference" : "ManufacturedItemDefinition/Levaxin-200mg-Tablet-SE-BS-MID"
    }
  ],
  "routeOfAdministration" : [
    {
      "code" : {
        "coding" : [
          {
            "system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
            "code" : "100000073619",
            "display" : "Oral use"
          }
        ]
      }
    }
  ]
}